Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q3 2016 |
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Recursion Pharmaceuticals, Inc. | 7 | Q2 2024 | 100.0% |
Babylon Holdings Ltd | 6 | Q1 2023 | 44.6% |
Teladoc Health, Inc. | 5 | Q4 2022 | 78.3% |
View Kinnevik AB (publ)'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
RECURSION PHARMACEUTICALS, INC. | May 22, 2023 | 10,405,668 | 5.6% |
Babylon Holdings Ltd | November 14, 2022 | 115,433,522 | 18.6% |
Teladoc Health, Inc. | April 15, 2021 | 7,491,124 | 4.9% |
Livongo Health, Inc.Sold out | November 03, 2020 | 0 | 0.0% |
MILLICOM INTERNATIONAL CELLULAR SASold out | January 21, 2020 | 0 | 0.0% |
View Kinnevik AB (publ)'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
N-PX | 2024-08-23 |
13F-HR | 2024-07-08 |
13F-HR | 2024-04-15 |
13F-HR | 2024-02-02 |
13F-HR | 2023-10-06 |
13F-HR | 2023-07-25 |
SC 13G | 2023-05-22 |
13F-HR | 2023-04-14 |
13F-HR | 2023-02-01 |
3 | 2022-12-30 |
View Kinnevik AB (publ)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.